Kemal EKİCİ, Öztun TEMELLİ, Ayse Fatma ERASLAN, ŞİMAY GÜROCAK, Nihal Kaplan BOZDAG, Emin Tamer ELKIRAN, Ersoy KEKİLLİ, Ahmet KIZILAY

Outcomes of radiotherapy in early stage glottic laryngeal carcinoma: a single center experience

Our aim was to determine the treatment outcomes and the prognostic factors affecting local control in early stage glottic carcinoma (ESGC) treated with definitive radiotherapy (RT). Between April 2003 and May 2015, 76 patients with ESGC were treated at Inonu University Hospital. There were 58 patients with T1a, 7 T1b and 11 with T2 tumors. Twenty-two patients were treated with conformal radiotherapy, 31 patients were treated with conventional RT and 23 patients were treated with intensity modulated radiotherapy as initial treatment. During a median follow-up of 51 months , 11 patients had failures. Five year overall survival rates were 73.7% in T1 and 81.8% T2. Local control rate was 85.5% in our patients. Patients who were over 61 years had significantly lower local control (p = 0.042). One patient treatment was interrupted because of grade 3 edema. One patient had grade 3 dermatitis, 2 patients grade 3 mucositis and 4 patients grade 3 edema, respectively. Our results suggest that curative radiotherapy is an effective treatment modality in ESGC without increasing toxicity. Age proved to be the only independent prognostic factor affecting local control after primary radiotherapy according to the results of this study

PDF

___

Amornmarn R, Prempree T, Viravathana T, Donavanik V, Wizenberg MJ. A therapeutic approach to early vocal cord carcinoma. Acta Radiol Oncol. 1985;24(4):321-5.

Tombolini V, Zurlo A, Cavaceppi P, Sarro A, Guidi C, Osti MF, Vitturini A, Banelli E. Radiotherapy for T1 carcinoma of the glottis. Tumori. 1995;81:414-8.

Zouhair A, Azria D, Coucke P, Matzinger O, Bron L, Moeckli R, Do HP, Mirimanoff RO, Ozsahin M. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension. Strahlenther Onkol. 2004;180(2):84-90.

Manzo R, Ravo V, Murino P, Morra A, Panetti G, Laudati A, Prisco A, Panelli G, Muto P. Outcomes of radiation therapy for T1 glottic carcinoma from an Italian regional series with doses ranging from 60 to 66 Gy. Tumori. 2010;96(4):577-81.

Rudoltz MS, Benammar A, Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys. 1993;26(5):767-72.

Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Bonetti B, Vitali E, De Stefani A, Buglione M, Biti G. Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys. 1195;63(5):1378-86.

Harada A, Sasaki R, Miyawaki D, Yoshida K, Nishimura H, Ejima Y, Kitajima K, Saito M, Otsuki N, Nibu K.Treatment outcomes of the patients with early glottic cancer treated with initial radiotherapy and salvaged by conservative surgery. Jpn J Clin Oncol. 2015;45(3):248- 55.

Garden AS, Forster K, Ang KK. Results of radiotherapy for T2N0 glottic carcinoma: does the '2' stand for twice-daily treatment? Int J Radiat Oncol Biol Phys. 2003;55(2):322-8.

Fein DA, Mendenhall WM, Parsons JT, Million RR. T1-2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. Int J Radiat Oncol Biol Phys. 1993;25(4):605-11.

Greisen O, Carl J, Pederson M. A consecutive series of patients with laryngeal carcinoma treated by primary irradiation. Acta Oncol. 1997;36(3):279-82.

Johansen LV, Grau C, Overgaard J. Glottic carcinoma - patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol. 2002;63(3):257-67.

Rydell R, Schalen L, Fex S, Elner A. Voice evaluation before and after laser excision vs. radiotherapy of T1A glottic carcinoma. Acta Otolaryngol. 1995;115(4):560-5.

Mendenhall WM, Hinerman RW, Amdur RJ, Mancusco AA, Villaret DB, Robbins KT. Larynx. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, editors. Principles and Practice of Radiation Oncology. 4th ed. Philadelphia, USA: Lippincott Williams&Wilkins, 2004, pp, 1094-16.

Groome PA, O'Sullivan B, Mackillop WJ, Jackson LD, Schulze K, Irish JC, Warde PR, Schneider KM, Mackenzie RG, Hodson DI, Hammond JA, Gulavita SP, Eapen LJ, Dixon PF, Bissett RJ. Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules. Int J Radiat Oncol Biol Phys. 2006;64(4):1002-12.

Esassolak M, Dubova S, Kamer S, Aydın B. Curative radiotherapy in early stage glottic laryngeal carcinoma. Türk Onkoloji Dergisi. 2006;21:28-36.

Hermans R, Feron M, Bellon E, Van den Bogaert W, Baert AL. Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. Int J Radiat Oncol Biol Phys. 1998;40(3):553-7.

Narayana A, Vaughan ATM, Kathuria S, Fisher SG, Walter SA, Reddy SP. p53 overexpression is associated with bulky tumor and poor local control in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 2000;46(1):21-6.

Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingley P, Levine MN. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328(3):159-63.

Warde P, O'Sullivan B, Bristow RG, Panzarella T, Keane TJ, Gullane PJ, Witterick IP, Payne D, Liu FF, McLean M, Waldron J,Cummings BJ.. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys. 1998;41(2):347-53.

Yu E, Shenouda G, Beaudet MP, Black MJ. Impact of radiation therapy fraction size on local control of early glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997;37(3):587-91.

Meydan D, Gürsel B, Sahin N, Özbek N. Erken evre glottik larenks kanserinde radyoterapi sonuçları: Tek merkez deneyimi. J Exp Clin Med. 2012;29:141-7.

Fowler JF, Lindström M. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 1992;23(2):457-67.

Teshima T, Chatani M, Inoue T. Radiation therapy for early glottic cancer (T1N0M0). II. Prospective randomized study concerning radiation field. Int J Radiat Oncol Biol Phys 1990;18(1):119-23.

Brady JS, Marchiano E, Kam D, Baredes S, Eloy JA, Park RC. Survival Impact of Initial Therapy in Patients with T1-T2 Glottic Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2016 Mar 29. Epub ahead of print.

Ermiş E, Teo M, Dyker KE, Fosker C, Sen M, Prestwich RJ.

Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions. Radiat Oncol. 2015;23;10:203.

Nozaki M, Furuta M, Murakami Y, Izawa Y, Iwasaki N, Takahashi H, Watanabe K. Radiation therapy for T1 glottic cancer: involvement of the anterior commissure. Anticancer Res. 2000;20(2B):1121-4.

Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S, Polli C, Livi L, Bonetti B, Vitali E, De Stefani A, Buglione M, Biti G. Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys. 2005;63(5):1378-86.

Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2006;64(1):77-82.

Van der Voet JC, Keus RB, Hart AA, Hilgers FJ, Bartelink H. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 1998;42(2):247-55.

Mendenhall WM, Amdur RJ, Morris CG, Hinerman RW. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 2001;19(20):4029-36.

Le Q-TX, Fu K, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM, Phillips TL. Influence of fractionation size, total dose, and overall treatment time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997;39(1):115-26.

Spector JG, Sessions DG, Chao KS, Hanson JM, Simpson JR, Perez CA. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery. Head Neck. 1999;21(2):116- 23.